PROGRAM DETAILS

Second Opinion

Immunotherapy in Cancer Treatment

Despite his initial prognosis of six to eight months to live, Ronald Eckert, MD, is thriving after undergoing a new immunotherapy treatment for stage 4 melanoma. Four years after the treatment, he feels he is cured and shares his story. Medical experts discuss the groundbreaking immunotherapy research and treatments being discovered each day in the area of cancers—treatments that will change the way we look at cancer.

Saturday, December 2 at 8:30 am on 12.2


additional airdates

    No additional airdates schedule at this time

upcoming episodes


past episodes


series description

SECOND OPINION focuses on health literacy in an engaging, entertaining and accessible way. The long-running series engages a panel of medical professionals and lay people in honest, in-depth discussions about life-changing medical decisions. SECOND OPINION seeks to improve doctor-patient communication, empower patients to take charge of their healthcare and, in turn, help them navigate the medical system for better health outcomes. Host Dr. Peter Salgo presents intriguing, real-life cases to experts representing every medical specialty, who then grapple with the diagnosis and treatment options. SECOND OPINION seeks to improve doctor-patient communication, empower patients to take charge of their healthcare and, in turn, help them navigate the medical system for better health outcomes.